Viridian Therapeutics shares surged 10.8% in pre-market trading after its drug for treating thyroid eye disease received approval from the U.S. Food and Drug Administration.

老虎证券2026/06/29 08:38

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This regulatory green light paves the way for the commercialization of the company's core product line, marking a key breakthrough in addressing this autoimmune disease. The market responded positively to this news, and investor sentiment was significantly boosted.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Viridian Therapeutics shares surged 10.8% in pre-market trading after its drug for treating thyroid eye disease received approval from the U.S. Food and Drug Administration.

You may also like

Crypto prices